Financiación
Investigador/a: Belén Palencia Coto
8 financiaciones - 2.418.402€
2023
2021
-
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
euro 459.800,00
-
Desarrolo preclinico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 y agonistas de STING
euro 23.000,00
-
CANCER ORGANOIDS COCULTURED WITH T CELLS AND FIBROBLASTS AS A NEW TOOL TO TEST AND
BENCHMARK IMMUNOTHERAPY STRATEGIES
euro 79.983,00
-
INTERLEUKIN-8 AND NEUTROPHIL EXTRACELLULAR TRAPS AS ACTIONABLE TARGET AND BIOMARKERS FOR CANCER IMMUNOTHERAPY
euro 213.555,00
2020
2018
-
H2020-ITN Tumor Treg Targeting
euro 247.873,00